文献速递胸部外周血管CT

用于呼吸困难患者的「三低」自由呼吸CT肺动脉造影方案

"Triple low" free-breathing CTPA protocol for patients with dyspnoea.
PubMed 文献 · Clin Radiol · 2022-06-07

本研究纳入134例呼吸困难并怀疑肺栓塞的患者,采用快速自由呼吸采集、固定35 ml小剂量对比剂和低曝光剂量的「三低」CTPA方案。肺动脉强化409 ± 159 HU,均>250 HU,平均DLP 145 ± 73 mGy·cm;90%(120/134)肺实质分析达最优,69%(92/134)肺动脈强化均匀至亚段水平,仅6%(8/134)无法判读。

要点

  • 「三低」自由呼吸CTPA方案在呼吸困难患者中可获得满足诊断的肺动脉强化,平均409 ± 159 HU,均>250 HU。
  • 肺实质分析在90%(120/134)病例中达最优,69%(92/134)肺动脈强化均匀至亚段水平,仅6%(8/134)无法判读。
  • 采集时间0.9–1.3秒,平均DLP 145 ± 73 mGy·cm,位于低剂量胸部CT范围。

核心结论

  • 「三低」自由呼吸CTPA方案可使呼吸困难患者在不被呼吸运动伪影妨碍的情况下便利地分析肺实质和肺动脉。

研究设计与样本

  • 本研究在选定的一组因怀疑肺栓塞而转诊行CTPA的呼吸困难患者中开展,共纳入134例;方案采用快速自由呼吸采集、固定小体积(35 ml)对比剂和低曝光剂量;记录肺动脉干和升主动脉的放射密度及剂量长度乘积(DLP),并对肺动脉强化和肺实质进行定性分析。

关键影像表现/征象

  • 肺动脉强化为409 ± 159 HU,系统性>250 HU。
  • 自由呼吸成像的采集时间为0.9至1.3秒。
  • 90%(120/134)病例的肺实质分析被认为达最优。
  • 69%(92/134)病例显示肺动脉强化均匀至亚段水平。
  • 仅6%(8/134)检查被认为无法判读。

诊断标准与关键数值

  • 肺动脉强化409 ± 159 HU,系统性>250 HU。
  • 平均DLP为145 ± 73 mGy·cm,位于低剂量胸部CT采集范围内。
  • 肺实质分析达最优者占90%(120/134)。
  • 肺动脉强化均匀至亚段水平者占69%(92/134)。
  • 无法判读的检查占6%(8/134)。

临床应用与阅片要点

  • 原文结论指出,该「三低」自由呼吸CTPA方案可使呼吸困难患者在不被呼吸运动伪影妨碍的情况下便利地分析肺实质和肺动脉。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To assess the performance of a "triple-low" free-breathing protocol for computed tomography pulmonary angiography (CTPA) evaluated on patients with dyspnoea and suspected pulmonary embolism and discuss its application in routine clinical practice for the study of the pulmonary parenchyma and vasculature.

MATERIAL AND METHODS: This study was conducted on a selected group of dyspnoeic patients referred for CTPA. The protocol was designed using fast free-breathing acquisition and a small, fixed volume (35 ml) of contrast agent in order to achieve a low-exposure dose. For each examination, radiodensity of the pulmonary trunk and ascending aorta, and the dose-length product (DLP) were recorded. A qualitative analysis was performed of pulmonary arterial enhancement and the pulmonary parenchyma.

RESULTS: This study included 134 patients. Contrast enhancement of the pulmonary arteries (409 ± 159 HU) was systematically >250 HU. The duration of acquisition ranged from 0.9 to 1.3 seconds for free-breathing imaging. The mean DLP was in the range of low-dose chest CT acquisitions (145 ± 73 mGy·cm). The analysis was deemed optimal in 90% (120/134) of cases for the pulmonary parenchyma. Sixty-nine per cent (92/134) of cases demonstrated homogeneous enhancement of the pulmonary arteries to the subsegmental level. Only 6% (8/134) of examinations were considered uninterpretable.

CONCLUSION: The present "triple-low" CTPA protocol allows convenient analysis of the pulmonary parenchyma and arteries without hindrance by respiratory motion artefacts in dyspnoeic patients.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Cantarinha, Bassil, Savignac, et al. "Triple low" free-breathing CTPA protocol for patients with dyspnoea. Clin Radiol. 2022. PMID: 35688771. doi:10.1016/j.crad.2022.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。